Palo Alto, CA, United States of America

Christopher J Evans

This inventor holds 3 USPTO granted patents. Top assignee: Leland Stanford Junior University. Active years: 1984-1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher J Evans. Retrieved from https://idiyas.com/inventor/christopher-j-evans-wkeea9yd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Palo Alto, CA (US) (1984 - 1986)
  • Redwood City, CA (US) (1986)

Company Filing History:


Years Active: 1984-1986

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Christopher J Evans

Introduction

Christopher J Evans is a notable inventor based in Palo Alto, CA. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative peptide research. With a total of 3 patents, Evans has established himself as a key figure in his area of expertise.

Latest Patents

Evans' latest patents include groundbreaking work on gastrin releasing peptide-like peptides. These novel peptides, characterized by the structures Ala-Pro-Val-Ser-Val-Gly-Gly-Gly-Thr-Val-Leu-Ala-Lys-Met-Tyr-Pro-NH.sub.2 and Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH.sub.2, have been isolated from rat and guinea pig brain extracts. They have also been synthesized using solid phase peptide synthesis methods. The GRP-like peptides are particularly useful as pharmaceuticals for various applications, including lowering body temperature, increasing respiratory activity, reducing food intake, stimulating pancreatic hormone release, stimulating pituitary hormone release, and suppressing thyroid hormone release in mammals. Another significant patent involves the use of Arg-Phe-amide derivatives, which provides a method for elevating blood pressure in mammals through the administration of a polypeptide containing the C-terminal residue L-Arg-L-Phe or its esters or amides.

Career Highlights

Evans is affiliated with Leland Stanford Junior University, where he continues to advance his research and contribute to the scientific community. His work has garnered attention for its potential impact on health and medicine.

Collaborations

Throughout his career, Evans has collaborated with esteemed colleagues, including Jack D Barchas and Eckard Weber. These partnerships have further enriched his research and innovation efforts.

Conclusion

Christopher J Evans is a distinguished inventor whose work in peptide research has led to significant advancements in pharmaceuticals. His contributions continue to influence the field and hold promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…